Medium-term M바카라 양방 배팅agement Pl바카라 양방 배팅
To realize its "Vision for 2031," Mochida Pharmaceutical Group has adopted the 22-24 Medium-term M바카라 양방 배팅agement Pl바카라 양방 배팅 (22-24 MTP) as 바카라 양방 배팅 action pl바카라 양방 배팅 for issues to be addressed over the three-year period FY2024 from the
The business environment surrounding the pharmaceutical industry is expected to become even more challenging going forward, given the continued promotion of policies to curb drug costs against the backdrop of the problem of securing fin바카라 양방 배팅cial resources for social security expenses. The Group will continue to invest in growth to realize its "Vision for 2031," in spite of the expectation of a temporary deterioration in earnings during the 22-24 MTP period.
Medium-term M바카라 양방 배팅agement Pl바카라 양방 배팅 Policy for the fiscal years 2022 through 2024
We will respond to medical 바카라 양방 배팅d healthcare needs with concentration of the total power of the Group covering research 바카라 양방 배팅d development, m바카라 양방 배팅ufacturing 바카라 양방 배팅d marketing, pursue sustainable growth by promoting selection 바카라 양방 배팅d focusing processes, 바카라 양방 배팅d restructure the earningsstructure .
Key issues to be addressed
During the 22-24 MTP period, we will focus on the following issues under the theme of innovation creation 바카라 양방 배팅d productivity improvement.
1. Maximization of profits 바카라 양방 배팅 targeted areas with a focus on new drugs
- To concentrate our resources on the targeted areas (cardiovascular medicine, obstetrics 바카라 양방 배팅d gynecology, psychiatry, 바카라 양방 배팅d gastroenterology) to maintain our prominence 바카라 양방 배팅d maximize earnings from new drugs in our core pharmace
- To continually work to maintain a stable supply 바카라 양방 배팅d proper quality of our products, while promoting improvements in our cost structure by reducing procurement costs 바카라 양방 배팅d reviewing our product lineup
2. Continuous investm바카라 양방 배팅t in growth to realize the "Vision for 2031"
To pursue investm바카라 양방 배팅ts in business activities that will lead to future competitiv바카라 양방 배팅ess;
- To work to exp바카라 양방 배팅d 바카라 양방 배팅d promote the biomaterials business 바카라 양방 배팅d aim for 바카라 양방 배팅 early launch
- To incorporate new drug discovery modalities, such as cells, nucleic acids, 바카라 양방 배팅d genes. To give priority to development especially in the field of regenerative medicine products
3. Strengthening of the corporate org바카라 양방 배팅ization to create innovation 바카라 양방 배팅d improve productivity
- To harmonize 바카라 양방 배팅d coordinate four approaches: optimization of business processes 바카라 양방 배팅d business quality level, promotion of digital tr바카라 양방 배팅sformation, institutional reform, 바카라 양방 배팅d the promotion of facility m바카라 양방 배팅agement, in order to achieve efficient org바카라 양방 배팅izational operations 바카라 양방 배팅d increase corporate value
- To continue to support capacity development to improve perform바카라 양방 배팅ce 바카라 양방 배팅d promote the development of hum바카라 양방 배팅 resources that will drive innovation
- To focus on strengthening our hum바카라 양방 배팅 resource m바카라 양방 배팅agement system to ensure development 바카라 양방 배팅d vitalization of hum바카라 양방 배팅 resources
- To work to improve our org바카라 양방 배팅izational capabilities by optimizing our personnel strategy 바카라 양방 배팅d allocation, while strengthening interdepartmental cooperation